I agree that this site is using cookies. You can find further informations here.
X
Millier, Aurélie
115  results:
Search for persons X
?
1

The Acceptance of Indirect Treatment Comparison Methods in ..:

Macabeo, Bérengère ; Rotrou, Théophile ; Millier, Aurélie..
PharmacoEconomics - Open.  8 (2023)  1 - p. 5-18 , 2023
Link: https://doi.org/10.1007/..
 
?
2

The burden of hospitalisations for COVID-19 in France: a st..:

Leboucher, Claire ; Blein, Cécile ; Machuron, Valérie...
Journal of Market Access & Health Policy.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
3

Public health impact of COVID-19 in French ambulatory patie..:

Millier, Aurélie ; Supiot, Romain ; Benyounes, Kelly...
Journal of Market Access & Health Policy.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
4

Real-world cost-effectiveness analysis of NOACs versus VKA ..:

Escobar Cervantes, Carlos ; Martí-Almor, Julio ; Cabeza, Alejandro Isidoro Pérez...
PLOS ONE.  17 (2022)  4 - p. e0266658 , 2022
Link: https://doi.org/10.1371/..
 
?
5

Real-world evidence for steroidal mineralocorticoid recepto..:

Folkerts, Kerstin ; Millier, Aurelie ; Smela, Beata...
Journal of Nephrology.  36 (2022)  4 - p. 1135-1167 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Health economic evaluation of gene replacement therapies: m..:

Aballéa, Samuel ; Thokagevistk, Katia ; Velikanova, Rimma...
Journal of Market Access & Health Policy.  8 (2020)  1 - p. 1822666 , 2020
Link: https://doi.org/10.1080/..
 
?
7

Real-world cost-effectiveness of rivaroxaban and apixaban v..:

Bowrin, Kevin ; Briere, Jean-Baptiste ; Levy, Pierre...
Journal of Market Access & Health Policy.  8 (2020)  1 - p. 1782164 , 2020
Link: https://doi.org/10.1080/..
 
?
8

Social Preferences for Orphan Drugs: A Discrete Choice Expe..:

Toumi, Mondher ; Millier, Aurélie ; Cristeau, Olivier...
Frontiers in Medicine.  7 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
9

Real-world cost-effectiveness of rivaroxaban compared with ..:

Bowrin, Kevin ; Briere, Jean-Baptiste ; Fauchier, Laurent...
PLOS ONE.  15 (2020)  1 - p. e0225301 , 2020
Link: https://doi.org/10.1371/..
 
?
10

Cultural Variations in Public Beliefs about Mental Disorder..:

Angermeyer, Matthias C. ; Carta, Mauro G. ; Ghachem, Rym...
Clinical Practice & Epidemiology in Mental Health.  16 (2020)  1 - p. 70-81 , 2020
Link: https://doi.org/10.2174/..
 
?
11

Cost-Effectiveness of Coronary and Peripheral Artery Diseas..:

Soini, Erkki ; Virtanen, Outi ; Väätäinen, Saku...
Advances in Therapy.  37 (2020)  7 - p. 3348-3369 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Impact of methodological choices on a meta-analysis of real..:

Briere, Jean-Baptiste ; Wu, Olivia ; Bowrin, Kevin...
Current Medical Research and Opinion.  35 (2019)  11 - p. 1867-1872 , 2019
Link: https://doi.org/10.1080/..
 
?
13

Health economic evaluation of rivaroxaban in the treatment ..:

Cowie, Martin R ; Lamy, André ; Levy, Pierre...
Cardiovascular Research.  116 (2019)  11 - p. 1918-1924 , 2019
Link: https://doi.org/10.1093/..
 
?
14

Cost-effectiveness analysis of pembrolizumab versus standar..:

Chouaid, Christos ; Bensimon, Lionel ; Clay, Emilie...
Lung Cancer.  127 (2019)  - p. 44-52 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Systematic review of utility values used in the pharmacoeco..:

Zhou, Junwen ; Millier, Aurélie ; François, Clément..
Journal of Market Access & Health Policy.  7 (2019)  1 - p. 1648973 , 2019
Link: https://doi.org/10.1080/..
 
1-15